Product Information
ABIRTEGA 250 MG TABLET is a generic product labeled by CivicaScript LLC, priced at $0.8305 per EA under NDC 82249001112. Its NADAC has been published 38 times since Oct 8, 2025.
Strength
250 mg/1
Manufacturer
CivicaScript LLCNDC
82249001112
Classification
Generic
Dosage Form
TABLET
Route
ORAL; ORAL
Last Updated
6/17/2026
Active Ingredients
ABIRATERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA208339On Market Since
11/23/2018
Pharmacological Classes
Price Statistics
The NADAC for ABIRTEGA 250 MG TABLET has been published 38 times since Oct 8, 2025, and over the history we have for it it has declined 21.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8305 per EA |
|---|---|
| All-time high | $1.0638 (Oct 15, 2025) |
| All-time low | $0.8305 (Jun 17, 2026) |
| 52-week high | $1.0638 |
| 52-week low | $0.8305 |
| Median price | $0.8567 |
| Average price | $0.8985 |
| Largest weekly change | -7.6% (Dec 17, 2025) |
| Weeks tracked | 38 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ABIRTEGA 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ABIRTEGA 250 MG TABLET, manufactured by CivicaScript LLC, is $0.8305 per EA (NDC 82249001112), effective Jun 24, 2026.
How has the price of ABIRTEGA 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ABIRTEGA 250 MG TABLET has declined 21.9%. It has been tracked across 38 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for ABIRTEGA 250 MG TABLET?
Since Oct 8, 2025, the NADAC for ABIRTEGA 250 MG TABLET has ranged from a low of $0.8305 (Jun 17, 2026) to a high of $1.0638 (Oct 15, 2025), with a median of $0.8567 per EA.
Are there cheaper alternatives to ABIRTEGA 250 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as ABIRTEGA 250 MG TABLET, but none are currently priced below it.
Who manufactures ABIRTEGA 250 MG TABLET?
ABIRTEGA 250 MG TABLET (NDC 82249001112) is labeled by CivicaScript LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification